Cancer Research UK Edinburgh Centre

Asier Unciti-Broceta

Innovative Therapeutics

Asier Unciti-Broceta
Dr Asier Unciti-Broceta - Reader

Research in a Nutshell 

The Innovative Therapeutics Lab is led by Dr Asier Unciti-Broceta and based at the CRUK Edinburgh Centre, part of the MRC Institute of Genetics and Molecular Medicine at the University of Edinburgh, where Asier established the first chemistry lab of the Institute in 2010. The lab explores novel chemical strategies to improve the efficacy and safety of cancer treatments. This includes development of highly-selective inhibitors of kinases involved in cancer and novel prodrug strategies aimed at improving the clinical use of well-established chemotherapy drugs.

 

Research Programme

 

Asier Unciti-Broceta group

People

 

Asier Unciti-Broceta

Principal Investigator and Reader

Belen Rubio-Ruiz Marie Curie Postdoctoral Fellow
Ana Perez-Lopez

EPSRC Postdoctoral Fellow

Catherine Adam

CRUK Postdoctoral Fellow

Sam Myers

PhD student

Thomas Bray

PhD student

Carolin Temps

PhD student

Beatrice Longo Erasmus student

Contact

Asier.Unciti-Broceta@igmm.ed.ac.uk

Collaborations

  • Professor Neil Carragher (ECRC)

  • Dr Liz Patton (ECRC)

  • Professor Val Brunton (ECRC)
  • Professor Margaret Frame (ECRC)
  • Professor H. Leung (Beatson Institute / University of Glasgow)
  • Dr P. Brennan (Centre for Clinical Brain Sciences / University of Edinburgh)
  • Dr D. Sieger (Centre for Neuroregeneration / University of Edinburgh)
  • Dr C. Torres-Sánchez (Loughborough University)
  • Dr R. Sanchez-Martín and Dr J. J. Díaz-Mochón (GENyO / Spain)
  • Professor I. Molina (University of Granada / Spain)  

Scientific Themes

Anticancer Therapy, Kinase Inhibitors, Bioorthogonal Prodrugs, Palladium Implants, Nanotechnology

Technology Expertise

Small Molecule Synthesis and Peptides, Medicinal Chemistry, Design and Development of Prodrugs, Target ID and Imaging Tools, Heterogeneous Catalysts